About Gerina
Gerina is a venture capital firm founded in 2000. It is primarily based out of Marburg, Germany. It primarily invests in Germany based startups. Its investments are spread across a wide range of sectors from Consumer to Life Sciences and Telecom. Overall, Gerina portfolio has seen 2 IPOs, namely Formycon and NanoRepro. Gerina has team of 4 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Gerina's List of Top Investments
Gerina has a portfolio of 10 companies. Their most notable investments include freenet.de and Formycon.Their portfolio spans across Germany and Switzerland. They have invested in Consumer, Life Sciences, Telecom and 6 other sectors. Here is the list of top investments by Gerina:
1. freenet.de
Online platform providing multi-category news. It offers news on various topics such as sports, finance, automobile, entertainment, lifestyle, and more. Also provides mail service and cloud-based storage services. Monetizes through display ads.
Key facts about freenet.de
- Founded Year: 2007
- Location: Budelsdorf (Germany)
- Stage: Funding Raised
- Employee Count: 52 as on Sep 30, 2026
- Investors: VCDE Venture Partners and Gerina
2. Formycon
Formycon is focussed on developing biosimilar drugs with the initial target on eye disorders. It currently has four biosimilars under development with the 2 ophthalmology biosimilar candidates licensed out to Santo Holding. The candidates are FYB201, a biosimilar of ranibizumab (Lucentis) in phase 1 trials for neovascular age-related macular degeneration (nAMD) and FYB203, a biosimilar for Eylea (aflibercept) for the treatment of nAMD and other serious eye conditions.
Key facts about Formycon
3. NanoRepro
NanoRepro develops & manufactures rapid diagnostic tests for consumers & professionals use. The company has a portfolio of 25+ quick tests including two pregnancy tests, a male fertility test, a gastric health test, and a range of various allergy and health screening tests. All these tests are immunochromatographic lateral flow tests (LFTs) to detect biomarkers.
Key facts about NanoRepro
4. DZ BANK
Key facts about DZ BANK
5. DZ BANK
Provider of commercial banking services including financing and capital markets. Operations include corporate banking, institutional banking, and transaction banking services. Offerings consist of investment products, risk management, hedging, and research analysis. The business facilitates access to financial markets for corporate and institutional entities.
Key facts about DZ BANK
IPOs and Publicly Listed companies in Gerina's Portfolio
2 of Gerina's portfolio companies have become public. Formycon got listed on the Frankfurt Stock Exchange (FRA), in Dec 2010 and NanoRepro got listed on the Frankfurt Stock Exchange (FRA) at marketcap of undefined.Here are Gerina's portfolio companies that went public:
Filter this listCompany | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 20, 2010 | - | - | 6692 | |
Oct 10, 2008 | - | - | 9018 |
Team profile of Gerina
Gerina has a team of 4 members including 4 Partners located in Germany. Gerina's team does not sit on the board of any company as of now.Here is a list of all team members in Gerina:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Frankfurt Am Main | - | ||
Partner | - | - | ||
Partner | - | - | - | |
Partner | Berlin | - | - |
